このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Epsilon Healthcare 過去の業績

過去基準チェック /06

Epsilon Healthcareの収益は年間平均-4.2%の割合で減少していますが、 Pharmaceuticals業界の収益は年間増加しています。収益は年間47.3% 16.1%割合で増加しています。

主要情報

-4.2%

収益成長率

9.1%

EPS成長率

Pharmaceuticals 業界の成長	31.2%
収益成長率	16.1%
株主資本利益率	-64.7%
ネット・マージン	-82.2%
前回の決算情報	30 Jun 2023

Recent updates

収支内訳

Epsilon Healthcare の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

ASX:EPN 収益、費用、利益 ( )AUD Millions
日付	収益	収益	G+A経費
30 Jun 23	7	-6	5
31 Mar 23	7	-10	6
31 Dec 22	7	-13	6
30 Sep 22	6	-13	7
30 Jun 22	5	-13	7
31 Mar 22	5	-11	8
31 Dec 21	5	-9	10
30 Sep 21	6	-9	11
30 Jun 21	7	-9	12
31 Mar 21	7	-10	11
31 Dec 20	7	-11	11
30 Sep 20	7	-11	11
30 Jun 20	6	-12	11
31 Mar 20	5	-12	10
31 Dec 19	5	-12	10
30 Sep 19	4	-11	9
30 Jun 19	4	-11	9
31 Mar 19	3	-10	9
31 Dec 18	3	-9	8
30 Sep 18	3	-7	7
30 Jun 18	3	-5	6
31 Mar 18	2	-4	5
31 Dec 17	2	-3	3

質の高い収益: EPNは現在利益が出ていません。

利益率の向上: EPNは現在利益が出ていません。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: EPNは利益が出ておらず、過去 5 年間で損失は年間4.2%の割合で増加しています。

成長の加速: EPNの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: EPNは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 16% ) と比較することは困難です。

株主資本利益率

高いROE: EPNは現在利益が出ていないため、自己資本利益率 ( -64.69% ) はマイナスです。

Epsilon Healthcare 過去の業績

過去 基準チェック /06

主要情報

最近の業績更新

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Recent updates

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Non-Executive Deputy Chairman recently bought AU$67k worth of stock

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Non-Executive Deputy Chairman recently bought AU$55k worth of stock

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

New minor risk - Share price stability

Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

Epsilon Healthcare Limited Announces Executive Changes

Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer

No independent directors

Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director

Epsilon Healthcare Limited Announces Board Changes

Epsilon Healthcare Limited Announces Resignation of Nicholas Marshall as Chief Financial Officer

Epsilon Healthcare Limited Announces Executive Changes

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Epsilon Healthcare Limited Announces Resignation of Dr. Rob Jenny as A Director

Epsilon Healthcare Limited Announces Resignation of Jarrod White as Chief Executive Officer

Epsilon Healthcare Limited Appoints Patrick Baiyu Xu as Director

Epsilon Healthcare Limited, Annual General Meeting, May 31, 2022

Epsilon Healthcare Limited announced that it expects to receive AUD 2.1 million in funding

No independent directors

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Epsilon Healthcare Limited announced that it expects to receive AUD 2.898 million in funding from CPS Capital

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Epsilon Healthcare Limited (ASX:EPN) entered into binding heads of agreement to acquire AlternaMed Pty Ltd. from Cannvalate PTY LTD for AUD 4.3 million.

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Joint Company Secretary Philip Leighfield has left the company

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Tetra Health Partners with Astrid Healthcare to Operates the Astrid Dispensary in South Yarra

Non Executive Director has left the company

Epsilon Healthcare Limited Announces Resignation of Gary Radcliff as Non-Executive Director

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Full year 2020 earnings released: AU$0.069 loss per share (vs AU$0.088 loss in FY 2019)

THC Global Group Limited announced that it expects to receive AUD 2.75 million in funding

New 90-day high: AU$0.29

THC Global Group Limited Announces CEO Changes

First half earnings released

New 90-day low - AU$0.24

New 90-day low - AU$0.26

THC Global Group Limited (ASX:THC) completed the acqusition of Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others.

New 90-day low - AU$0.27

THC Global Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.535 million.

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

過去基準チェック /06